Harbin Yew Science and Technology Development

Harbin Yew Science and Technology Development is a specialized pharmaceutical company based in China that focuses on the production of taxane-based anti-cancer drugs. The company operates extensive Taxus (yew tree) plantations to ensure a sustainable supply of raw materials for the extraction of Paclitaxel and its precursors, such as 10-Deacetylbaccatin III (10-DAB III). As a major API manufacturer, it provides high-purity compounds to global pharmaceutical partners for the formulation of chemotherapy treatments. Their business model integrates biotechnology research, large-scale cultivation, and advanced chemical purification processes. The company's facilities are GMP-certified, ensuring that their products meet international quality standards for oncology therapeutics. By focusing on natural product extraction, they play a critical role in the supply chain for life-saving cancer medications.